参议院确认听证会往往充斥着模糊的承诺和回避性回答。但当现任疾病控制与预防中心（CDC）主任埃里卡·施瓦茨（Erica Schwartz）宣称：“参议员，我向您承诺。”时，情况并非如此。她是在确认收集堕胎数据是其机构工作的重要组成部分。
Senate confirmation hearings are often filled with vague promises and deflective answers. But this was not the case when now-Director Erica Schwartz of the Centers for Disease Control and Prevention declared, “Senator, you have my commitment.“ She was affirming that data collection on abortion is a critical component of her agency’s work.
为了女性及其医疗服务提供者的利益，施瓦茨主任必须遵守她的承诺。
For the sake of women and their healthcare providers, Director Schwartz must keep to her word.
全国堕胎数据收集的历史比罗伊诉韦德案本身更早。随着各州在20世纪60年代末开始放宽堕胎法律，CDC建立了堕胎监测系统，以跟踪与堕胎相关的孕产妇死亡和发病率，收集寻求堕胎人群的人口统计信息，并监测非计划妊娠。
National abortion data collection is older than Roe v. Wade itself. As states began to liberalize their abortion laws in the late 1960s, the CDC established the Abortion Surveillance System to track abortion-related maternal mortality and morbidity, collect demographics of abortion-seeking populations, and monitor unintended pregnancies.
自愿的州级报告措施被正当地视为必要的公共卫生控制。只有在堕胎合法化运动将女性安全置于堕胎获取之下后，这些措施才与反堕胎努力相关联。
Voluntary state reporting measures were rightfully deemed necessary public health controls. These only became associated with anti-abortion efforts after women’s safety had been subordinated to abortion access by the abortion legalization movement.
CDC自1969年以来每年发布一次堕胎监测系列，传统上在11月下旬发布。尽管已知存在低报，但该系列对于知情同意实践至关重要，使女性及其提供者在决定妊娠时能够获得与堕胎相关的全部风险信息。
The CDC has published its annual abortion surveillance series since 1969, traditionally in late November. Despite known underreporting, this series is critical for informed consent practices, allowing women and their providers access to the full scope of risks associated with abortion when making decisions about their pregnancy.
然而，自系列开始以来，首次出现CDC未能在2025年发布该报告的情况，理由是机构削减。该缺失的报告本应包括2023年的堕胎监测数据，即Dobbs判决后的第一年。该年尤为重要，因为罗伊案后堕胎法律的变化在2022年底尚未稳定。州级限制仍在持续诉讼中，许多法律面临即时禁令。
But for the first time since the series outset, the CDC failed to publish this report in 2025, citing agency cutbacks. This missed report notably was to include abortion surveillance from 2023, the first year following the Dobbs decision. That year is especially important because the shifting landscape of abortion law in the fallout of Roe had not settled by the end of 2022. State restrictions were subject to ongoing litigation, and many laws faced immediate injunctions.
堕胎服务提供者也越来越多地转向远程医疗配药模式，以规避旨在遏制全国堕胎数量的州级法律。2023年的监测数据将提供一幅首幅图景——无论多么模糊或不完整——让女性了解多布斯案判决后的堕胎风险。
Abortion providers have also shifted increasingly toward telehealth dispensing models, circumventing state-level laws intended to curb national abortion numbers. Surveillance from 2023 will offer a first picture, however blurred or incomplete, that women will have into abortion risk post-Dobbs.
遗憾的是，正如近期新闻所显示的，未能及时发布堕胎安全报告似乎已成为该政府的一个主题。堕胎辩论的双方以及主流媒体都高度关注食品药品监督管理局（FDA）对药物堕胎药米非司酮的审查，以及公开结果持续推迟至明年3月。但这种对长达半个多世纪纵向堕胎数据收集的漠视，也是对该政府“黄金标准科学”格言的背离，并引发了关于其对自身透明度标准承诺的质疑。
Unfortunately, as recent news suggests, failure to provide timely reports on abortion safety seems to be a theme for this administration. Both sides of the abortion debate, and the mainstream media, are focused heavily on the Food and Drug Administration’s review of the medication abortion drug, mifepristone, and the continued delay of public results until next March. But this disregard of more than half a century of longitudinal abortion data collection is also a departure from the administration’s “Gold Standard Science” maxim and raises questions about the commitment to its own transparency standard.
施瓦茨局长，即便抛开她在参议员乔什·霍利（共和党-密苏里州）的确认听证会上作出的承诺，也必须优先发布多布斯案判决后的这些数据，并确保2026年的报告按时发布。
Director Schwartz, even aside from the commitment she made in her confirmation hearing to Sen. Josh Hawley (R-Mo.), must prioritize the release of this post-Dobbs data and ensure the 2026 report is released on time.
公共卫生是为民众服务的。不能因为担心数据会被意识形态分子利用为武器而隐瞒数据。尽管联邦堕胎政策日益演变为一场数据战，但监测数据为监管行动提供依据，以保护女性免受潜在伤害。隐瞒数据就是强迫女性在黑暗中做决定。
Public health is a service to the populace. Data cannot be withheld for fear it will be weaponized by ideologues. Although federal abortion policy has increasingly become a data war, surveillance informs regulatory action to protect women from potential harms. To hide data is to force women to make decisions in the dark.
此外，虽然只有国会拥有强制各州提交联邦报告的权力，但这并不免除疾控中心（CDC）向各州提供自上而下标准的责任，该标准应反映应报告哪些患者去标识化数据要素。
Moreover, although Congress alone has the authority to mandate federal reports from the states, but that does not leave the CDC without responsibility to provide the states with a top-down standard that reflects what patient-deidentified elements should be reported.
在多布斯案之后的时代，药物流产占所有流产的近三分之二，疾控中心应要求各州自愿提供规格说明，以实现政府间对药物使用合规性的问责。为确保遵守联邦药品法规，各州还应追踪并报告处方堕胎药的序列号和批号，以及药品有效期。
In the era following Dobbs, where medication abortions comprise nearly two-thirds of all abortions, the CDC should request that states volunteer specifications that enable intergovernmental accountability for compliance with the drug’s use. To ensure compliance with federal drug regulations, states should also track and report the serial and lot numbers for abortion drugs prescribed along with drug expiration dates.
即使在有堕胎保护法的州，这些法律保护州外开方者将堕胎药邮寄给在堕胎非法的州的女性，使其免受刑事和民事处罚，疾控中心也应要求各州记录开具药物的堕胎服务提供者、开方者所在州，以及药物流产是在提供者的机构完成还是在家中完成——当然，要对所有患者信息保密。
And even in states where abortion shield laws protect out-of-state prescribers from criminal and civil penalties for mailing abortion drugs to women in states where it is illegal, the CDC should request that states record the abortion providers who prescribe the drugs, the prescriber’s state, and whether the medication abortion was completed at the provider’s facility or at home — of course keeping all patient information confidential.
公共卫生组织不是政治棋子。施瓦茨不得放弃疾控中心对数据透明度的承诺，也不得放弃对其所服务的女性和医疗服务提供者的承诺。
Public health organizations are not political pawns. Schwartz must not forfeit the CDC’s commitment to data transparency, or to the women and healthcare providers it informs.
加文·奥克斯利是“美国人联合捍卫生命”组织的对外事务与媒体战略总监。
Gavin Oxley is director of external affairs and media strategy for Americans United for Life.